You are here

Healthcare Economics

 

Deerfield Management agreed to provide Endologix, Inc. with up to $170 million in funding, including a $120 million, six-year secured term loan and a $50 million, three-year secured asset-based revolving line of credit.

The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott on April 12 alerting the company of violations at its manufacturing facility in Sylmar, California.

New research from a veteran-focused healthcare provider shows that U.S. veterans suffering from heart disease and depression are more likely to struggle receiving regular healthcare access and paying bills compared to those that don’t face mental health challenges. 

A new study conducted by the Canadian Pharmacists Association found that comprehensive, long-term pharmacist care for Canadians suffering from hypertension could improve outcomes and save more than $15.7 billion.

Between 1992 and 2014, the rate of paid malpractice claims decreased 13.5 percent in cardiology and declined 55.7 percent in all medical specialties, according to a database analysis.

 

Recent Headlines

MyoKardia appoints physician, executive David Meeker to board of directors

MyoKardia named pharmaceutical executive and physician David Meeker, MD, to its board of directors on April 18.

Deerfield Management provides Endologix with up to $170 million in funding

Deerfield Management agreed to provide Endologix, Inc. with up to $170 million in funding, including a $120 million, six-year secured term loan and a $50 million, three-year secured asset-based revolving line of credit.

FDA sends warning letter to Abbott regarding issues at California facility

The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott on April 12 alerting the company of violations at its manufacturing facility in Sylmar, California.

Trends in U.S. malpractice claims significantly change from 1992 to 2014

Between 1992 and 2014, the rate of malpractice claims paid on behalf of U.S. physicians declined 55.7 percent, while the mean compensation payment increased 23.3 percent.

Terumo Cardiovascular names Robert DeRyke as CEO, president

Terumo Cardiovascular Group in Ann Arbor, Michigan, promoted Robert DeRyke to become the company’s CEO and president.

Veterans with heart disease, depression have trouble affording healthcare

New research from a veteran-focused healthcare provider shows that U.S. veterans suffering from heart disease and depression are more likely to struggle receiving regular healthcare access and paying bills compared to those that don’t face mental health challenges. 

Espero Pharmaceuticals, Armetheon plan to merge, focus on cardiovascular medications

Espero Pharmaceuticals and Armetheon announced on March 30 that they planned on merging to form a company focused on developing cardiovascular medications. Both companies are privately held.

Abiomed celebrates $40 million expansion to Massachusetts headquarters

During a ceremony on March 30, Massachusetts Governor Charlie Baker and others celebrated the grand opening of Abiomed’s expanded headquarters in Danvers, Massachusetts.

Treating hypertension with pharmacist care could save Canadians $15.7 billion

A new study conducted by the Canadian Pharmacists Association found that comprehensive, long-term pharmacist care for Canadians suffering from hypertension could improve outcomes and save more than $15.7 billion.

Rates of paid malpractice claims decrease in cardiology, other medical specialties

Between 1992 and 2014, the rate of paid malpractice claims decreased 13.5 percent in cardiology and declined 55.7 percent in all medical specialties, according to a database analysis.

Pages